• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

按病因和严重程度划分的日本成年人群视力损害患病率及未来预测。

Prevalence of visual impairment in the adult Japanese population by cause and severity and future projections.

作者信息

Yamada Masakazu, Hiratsuka Yoshimune, Roberts Chris B, Pezzullo M Lynne, Yates Katie, Takano Shigeru, Miyake Kensaku, Taylor Hugh R

机构信息

National Institute of Sensory Organs, National Tokyo Medical Center, Tokyo, Japan.

出版信息

Ophthalmic Epidemiol. 2010 Jan-Feb;17(1):50-7. doi: 10.3109/09286580903450346.

DOI:10.3109/09286580903450346
PMID:20100100
Abstract

PURPOSE

To present a comprehensive estimate of the total number of people with visual impairment in the adult Japanese population by age, gender, severity and cause, and to estimate future prevalence based on population projections and expected demographic changes.

METHODS

Definitions of visual impairment used in this study were based on the United States criteria. Total visual impairment was calculated as the sum of low vision and blindness. The prevalence estimates were based on input from a number of Japanese epidemiological surveys, census material and official population projections.

RESULTS

There were an estimated 1.64 million people with visual impairment in 2007 in Japan. Of these, 187,800 were estimated to be blind. The prevalence of visual impairment in Japan increased with age and half of the people with visual impairment were aged 70 years or older. The leading causes of visual impairment in Japan were glaucoma (24.3%), diabetic retinopathy (20.6%), degenerative myopia (12.2%), age-related macular degeneration (10.9%), and cataract (7.2%). These five major causes comprised three-quarters of all visual impairment. The prevalence of visual impairment was projected to increase from 1.3% of the population in 2007 to 2.0% by 2050.

CONCLUSIONS

This comprehensive study presents the prevalence of total visual impairment in the adult Japanese population. The projected increases in the prevalence of visual impairment over time reflect the demographic changes of a declining and aging Japanese population. These projections highlight that the burden of disease due to visual impairment and imposed on society is likely to increase.

摘要

目的

按年龄、性别、严重程度和病因,全面估算日本成年人口中视力障碍者的总数,并根据人口预测和预期人口结构变化估算未来的患病率。

方法

本研究中使用的视力障碍定义基于美国标准。总视力障碍为低视力和盲的总和。患病率估算基于多项日本流行病学调查、人口普查资料和官方人口预测的数据。

结果

2007年日本估计有164万视力障碍者。其中,估计有187,800人失明。日本视力障碍的患病率随年龄增长而上升,半数视力障碍者年龄在70岁及以上。日本视力障碍的主要病因是青光眼(24.3%)、糖尿病视网膜病变(20.6%)、变性近视(12.2%)、年龄相关性黄斑变性(10.9%)和白内障(7.2%)。这五大病因占所有视力障碍的四分之三。预计到2050年,视力障碍的患病率将从2007年的1.3%升至2.0%。

结论

这项综合研究展示了日本成年人口中总视力障碍的患病率。预计视力障碍患病率随时间上升反映了日本人口减少和老龄化的人口结构变化。这些预测突出表明,视力障碍给社会带来的疾病负担可能会增加。

相似文献

1
Prevalence of visual impairment in the adult Japanese population by cause and severity and future projections.按病因和严重程度划分的日本成年人群视力损害患病率及未来预测。
Ophthalmic Epidemiol. 2010 Jan-Feb;17(1):50-7. doi: 10.3109/09286580903450346.
2
Causes of blindness and visual impairment in urban and rural areas in Beijing: the Beijing Eye Study.北京城乡地区失明和视力损伤的病因:北京眼病研究
Ophthalmology. 2006 Jul;113(7):1134.e1-11. doi: 10.1016/j.ophtha.2006.01.035. Epub 2006 May 2.
3
Causes and prevalence of visual impairment among adults in the United States.美国成年人视力障碍的成因及患病率。
Arch Ophthalmol. 2004 Apr;122(4):477-85. doi: 10.1001/archopht.122.4.477.
4
Prevalence and Causes of Visual Impairment in a Chinese Adult Population: The Taizhou Eye Study.中国成人人群视力障碍的患病率及病因:台州眼科研究。
Ophthalmology. 2015 Jul;122(7):1480-8. doi: 10.1016/j.ophtha.2015.03.022. Epub 2015 May 16.
5
Prevalence and causes of visual impairment and blindness among 9980 Scandinavian adults: the Copenhagen City Eye Study.9980名斯堪的纳维亚成年人视力损害和失明的患病率及原因:哥本哈根市眼病研究
Ophthalmology. 2004 Jan;111(1):53-61. doi: 10.1016/j.ophtha.2003.05.010.
6
Visual Impairment and Blindness in Adults in the United States: Demographic and Geographic Variations From 2015 to 2050.美国成年人的视力障碍和失明:2015 年至 2050 年的人口统计学和地理差异。
JAMA Ophthalmol. 2016 Jul 1;134(7):802-9. doi: 10.1001/jamaophthalmol.2016.1284.
7
Prevalence and causes of low vision and blindness in a rural chinese adult population: the Handan Eye Study.中国农村成年人群低视力和盲的患病率及病因:邯郸眼病研究
Ophthalmology. 2008 Nov;115(11):1965-72. doi: 10.1016/j.ophtha.2008.05.030. Epub 2008 Aug 5.
8
Effects of an Aging Population and Racial Demographics on Eye Disease Prevalence: Projections for Georgia Through 2050.人口老龄化和种族人口结构对眼病患病率的影响:到 2050 年对佐治亚州的预测。
Am J Ophthalmol. 2020 Feb;210:35-40. doi: 10.1016/j.ajo.2019.10.028. Epub 2019 Nov 9.
9
Estimates of Incidence and Prevalence of Visual Impairment, Low Vision, and Blindness in the United States.美国视力障碍、低视力和盲症的发病率和患病率估计。
JAMA Ophthalmol. 2018 Jan 1;136(1):12-19. doi: 10.1001/jamaophthalmol.2017.4655.
10
Trends in prevalence of blindness and distance and near vision impairment over 30 years: an analysis for the Global Burden of Disease Study.30 多年来盲症和远距离及近距离视力损伤流行率的变化趋势:全球疾病负担研究的分析。
Lancet Glob Health. 2021 Feb;9(2):e130-e143. doi: 10.1016/S2214-109X(20)30425-3. Epub 2020 Dec 1.

引用本文的文献

1
The role of inflammation in myopic retinopathy.炎症在近视性视网膜病变中的作用。
Front Ophthalmol (Lausanne). 2025 Aug 20;5:1632047. doi: 10.3389/fopht.2025.1632047. eCollection 2025.
2
Myopia and high myopia trends in Chinese children and adolescents over 25 years: a nationwide study with projections to 2050.25年来中国儿童和青少年近视及高度近视的发展趋势:一项全国性研究及到2050年的预测
Lancet Reg Health West Pac. 2025 Jun 11;59:101577. doi: 10.1016/j.lanwpc.2025.101577. eCollection 2025 Jun.
3
Association between statin use and cataract formation in a retrospective cohort study using Japanese health screening and claims data.
一项利用日本健康筛查和理赔数据的回顾性队列研究中他汀类药物使用与白内障形成之间的关联。
Sci Rep. 2025 Apr 19;15(1):13594. doi: 10.1038/s41598-025-97889-1.
4
Association Between Visual Impairment and Daily Internet Use Among Older Japanese Individuals: Cross-Sectional Questionnaire Study.日本老年人视力障碍与日常互联网使用之间的关联:横断面问卷调查研究
JMIR Form Res. 2024 Dec 9;8:e58729. doi: 10.2196/58729.
5
Clustered ARPE-19 cells distinct in mitochondrial membrane potential may play a pivotal role in cell differentiation.聚集的 ARPE-19 细胞在线粒体膜电位上存在差异,可能在细胞分化中发挥关键作用。
Sci Rep. 2024 Sep 27;14(1):22391. doi: 10.1038/s41598-024-73145-w.
6
Switching to Intravitreal Brolucizumab after Ranibizumab or Aflibercept Using Treat and Extend Regimen for Neovascular Age-Related Macular Degeneration in Japanese Patients: 1-Year Results and Factors Associated with Treatment Responsiveness.在日本患者中,使用治疗并延长方案,在雷珠单抗或阿柏西普治疗后改用玻璃体内注射布罗达单抗治疗新生血管性年龄相关性黄斑变性:1年结果及与治疗反应相关的因素
J Clin Med. 2024 Jul 26;13(15):4375. doi: 10.3390/jcm13154375.
7
Nutraceuticals for Diabetic Retinopathy: Recent Advances and Novel Delivery Systems.用于糖尿病视网膜病变的营养药物:最新进展与新型传递系统。
Nutrients. 2024 May 30;16(11):1715. doi: 10.3390/nu16111715.
8
Myopia Is an Ischemic Eye Condition: A Review from the Perspective of Choroidal Blood Flow.近视是一种缺血性眼病:基于脉络膜血流视角的综述
J Clin Med. 2024 May 9;13(10):2777. doi: 10.3390/jcm13102777.
9
Five-year outcomes of treat and extend regimen using intravitreal aflibercept injection for treatment-naïve age-related macular degeneration.治疗初发年龄相关性黄斑变性的玻璃体腔内注射阿柏西普的“治疗即扩展”方案的 5 年结果。
Graefes Arch Clin Exp Ophthalmol. 2024 Nov;262(11):3483-3491. doi: 10.1007/s00417-024-06519-5. Epub 2024 May 17.
10
Long-term outcomes of anti-vascular endothelial growth factor therapy with and without posterior scleral reinforcement on myopic maculopathy in myopic choroidal neovascularization eyes.抗血管内皮生长因子治疗联合和不联合后巩膜加固治疗近视脉络膜新生血管性近视性黄斑病变的长期疗效。
BMC Ophthalmol. 2024 Mar 13;24(1):118. doi: 10.1186/s12886-024-03357-1.